Clinical Trials Browser

Phase 2 × Leukemia, Myeloid, Acute × MLN 8237 × Clear all

NCT02560025 2020-05-05

Phase II Trial of Alisertib With Induction Chemotherapy in High-risk AML

Phase 2 Completed

42 enrolled 12 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00830518 2018-05-11

A Phase 2 Trial of MLN8237 in Adult Participants With Acute Myelogenous Leukemia and High-Grade Myelodysplastic Syndrome

Phase 2 Completed

57 enrolled 21 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute